Glaukos GKOS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Corneal Health | $21.31M-11.1% | $23.97M+2.9% | $23.29M+13.1% | $20.59M+11.1% | $18.53M-13.2% | |
| Glaucoma | $129.26M+8.5% | $119.15M+8.1% | $110.25M+6.5% | $103.53M+17.5% | $88.14M+4.7% | |
| Revenue by Geography | ||||||
| Non Us | $38.23M+8.8% | $35.12M+9.5% | $32.09M-4.5% | $33.6M+6.4% | $31.59M+5.6% | |
| US | $112.34M+4.0% | $108M+6.5% | $101.45M+12.1% | $90.52M+20.6% | $75.07M-0.7% | |
| PP&E (Net) by Geography | ||||||
| Non Us | $273K+37.2% | $199K+4.2% | $191K+4.9% | $182K+7.1% | $170K+20.6% | |
| US | $112.16M-0.8% | $113.05M+2.1% | $110.75M-0.8% | $111.63M+15.5% | $96.64M-1.1% | |
| Capital Expenditure by Geography | ||||||
| Non Us | $123K+392% | $25K+4.2% | $24K+41.2% | $17K-48.5% | $33K— | |
| US | $3.84M+32.7% | $2.89M+79.4% | $1.61M+38.8% | $1.16M-39.1% | $1.91M+11.7% | |
| D&A by Geography | ||||||
| Non Us | $11K-8.3% | $12K-7.7% | $13K0.0% | $13K+8.3% | $12K+33.3% | |
| US | $11.79M-3.0% | $12.15M+33.2% | $9.12M+6.6% | $8.56M+4.2% | $8.22M-5.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
